出血防止ジェルの世界市場

出血防止ジェルの世界市場は2030年までに78億米ドルに到達

2024年に59億米ドルと推定される出血防止ジェルの世界市場は、分析期間2024-2030年にCAGR 4.8%で成長し、2030年には78億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである動物用抗出血ゲルは、CAGR 5.7%を記録し、分析期間終了までに50億米ドルに達すると予測されます。ヒト用抗出血ゲル分野の成長率は、分析期間中CAGR 3.3％と推定されます。

米国市場は16億米ドルと推定、中国はCAGR 8.9％で成長予測

米国の出血防止ジェル市場は、2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに17億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9%と3.8%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の出血防止ジェル市場- 主要動向と促進要因のまとめ

出血防止ジェルが救急医療や外科医療で勢いを増す理由とは？

医療における出血防止ジェルへの依存の高まりは、外傷や外科的対応における大きな進歩を意味します。従来、出血のコントロールには、ガーゼ、縫合糸、手による圧迫の組み合わせが用いられてきましたが、これらの方法は時間がかかり、重傷や複雑な損傷ではしばしば不十分なことがありました。出血防止ジェルは、これとは対照的に、傷口に直接塗布して数秒で血流を止めることができる、即効性のある非常に効果的な代替品を提供します。これらのゲルは、体内の自然な凝固メカニズムを促進し、安定したバリアを形成して出血を止め、傷口をさらなる傷害から保護します。このジェルの使用は、戦場、救急車内、自然災害時などの救急医療において特に普及しています。手術チームも、術中・術後の出血を最小限に抑え、合併症や輸血の必要性を減らすために、出血防止ジェルを採用しています。その魅力は汎用性にあります。表面的な切り傷、深い裂傷、内部の手術部位にも同様に使用できます。多くの場合、ジェルは手術時間を短縮し、治癒をサポートする清潔で密封された創傷環境を作り出すことにより、患者の回復を促進します。コンパクトで使いやすいパッケージは、現場医療従事者や救急隊員にとって理想的であり、無菌製剤は手術室プロトコールとの適合性を保証します。ヘルスケアの専門家がより迅速で効率的な出血管理方法を求める中、これらのゲルは特殊なものから、外傷用キット、手術用パック、家庭用救急用品の定番品へと移行しつつあり、管理された環境と管理されていない環境の両方における出血管理方法のパラダイムシフトを意味しています。

生体工学の進歩は、出血防止ジェルの性能をどのように高めているのでしょうか？

出血防止ジェルの有効性と安全性は、生体材料科学と生体医工学の飛躍的進歩により、著しく向上しました。初期の製剤は基本的な多糖類とゲルベースのマトリックスに依存していましたが、最新の製剤は身体の自然な止血プロセスと相乗的に働く生物活性剤を含むように進歩しました。今日の出血防止ジェルの多くは、キトサン、コラーゲン、酸化セルロース、合成ポリマーなどの物質で構成されており、それぞれが特定のタイプの出血や組織相互作用に合うように調整されています。これらの物質は血小板の凝集を促すだけでなく、活発な出血時に重要な特徴である、濡れた組織にしっかりと接着する物理的な密閉を作り出します。トロンビンやフィブリノゲンなどの凝固因子をゲルマトリックスに組み込むことで、凝固速度や効果がさらに向上しました。さらに、現在では抗菌特性を持つゲルも開発されており、出血コントロールと感染予防を兼ね備えています。生分解性ゲルや生体吸収性ゲルも出現しており、これらは時間の経過とともに体内で自然に溶解し、除去の必要がなくなるため、患者の不快感や二次的合併症のリスクを軽減します。ナノ工学の革新により、表面積の増大、組織接着性の向上、反応性の高速化など、より信頼性が高く予測可能な結果をもたらすゲルの製造が可能になりました。さらに、粘度を調節したり、凝固剤を制御された用量で放出したりすることで、出血の重症度に対応できるスマート・ゲルの研究も進行中です。このような技術的進歩は、日常的な臨床現場での転帰を改善するだけでなく、従来のツールでは不十分な場面での救命介入を可能にし、このカテゴリーの製品に対する世界の需要をさらに拡大しています。

なぜ臨床医やヘルスケア機関は出血防止ジェルを急速に実践に取り入れているのでしょうか？

患者の安全性、治療の効率性、手術の正確性が重視されるようになり、出血防止ジェルを標準的な医療プロトコルに組み込むヘルスケア機関が増えています。整形外科、心臓血管外科、歯科、婦人科、脳神経外科など、様々な専門分野の外科手術において、出血をコントロールすることは、視認性を高めるだけでなく、手術時間を短縮し、合併症のリスクを軽減するために不可欠です。出血防止ジェルは、従来の焼灼術や縫合術に伴う遅延なしに、軽度および中等度の出血を管理するための清潔で迅速なソリューションを提供します。特に、出血部位へのアクセスが制限され、従来の方法が実用的でない低侵襲手術に有用です。手術室以外でも、これらのゲルは外来患者や在宅医療の現場で使用されており、出血創、潰瘍、さらには鼻血を治療するための携帯可能で効率的なツールを臨床医に提供しています。外傷治療室では、凝固障害のある患者の出血管理に役立っています。さらに、その使いやすさは最小限の訓練で済むため、救急隊員、軍医、災害対応チームの救急キットに加える貴重な存在となっています。病院や診療所もまた、再入院率や術後合併症を減らさなければならないというプレッシャーの高まりに対応しており、出血防止ジェルは、手術部位での長引く出血や感染症に関連するリスクを最小限に抑える役割を担っています。輸血のような血液製剤の使用量を減らすことは、施設のコスト抑制戦略や患者の安全性の目標とも一致します。高齢者や医学的に複雑な患者を対象とする手術が増加する中、臨床医は信頼性、無菌性、迅速性を提供する技術やツールを優先しています。

出血防止ジェルの世界市場成長を促進する要因は？

出血防止ジェル市場の成長は、ヘルスケア動向、製品イノベーション、臨床実践の変化に関連するいくつかの重要な要因によって牽引されています。特に、過剰な組織外傷を伴わず、正確で局所的な止血を必要とする選択的手術や低侵襲手術が世界的に増加していることが主な要因です。さらに、交通事故、自然災害、武力紛争などによる外傷の急増が、携帯可能で即効性のある出血制御ソリューションに対する強い需要を生み出しています。もう一つの重要な要因は、慢性疾患や治癒遅延、凝固障害を起こしやすい世界の高齢化であり、高度な止血介入に対する持続的なニーズが生じています。生体適合性と多機能性を備えたゲル製剤の革新は、病院の手術室から外来診療所、さらには戦場環境まで、これらの製品を使用できる医療環境の幅を広げています。歯科手術、皮膚科処置、スポーツ医学における出血防止ジェルの採用拡大も、メーカーに新たな収益源をもたらしています。さらに、感染症、免疫反応、供給不足など輸血に関連する危険性に対する意識の高まりが、医療従事者を失血やドナー血液への依存を減らす代替療法へと向かわせています。特に北米と欧州では、規制当局の承認が良好であるため、新しい製剤の商業化が加速しています。高度な手術器具へのアクセスが限られている新興国では、出血防止ジェルは費用対効果が高く、インパクトの大きいソリューションを提供するため、市場の地理的な広がりを見せています。バイオテクノロジー企業と医療流通業者との戦略的パートナーシップは、研究開発への投資の増加とともに、技術革新と世界的普及をさらに加速させています。これらの要因が相まって、出血防止ジェルは持続的な成長の基盤が築かれ、現代の創傷治療や外科診療にますます欠かせない要素となっています。

セグメント

製品（動物用出血防止ゲル、ヒト用出血防止ゲル）、適応症（軟部組織の生検、外傷、核出術、整形外科手術、その他の適応症）、流通チャネル（小売薬局流通チャネル、オンライン流通チャネル、動物用薬局流通チャネル、その他の流通チャネル）

調査対象企業の例（注目の44社）

• 3M
• Aesculap（B. Braun Melsungen）
• AngioDynamics
• Aspen Surgical
• Baxter International Inc.
• Biom'up
• Bioventus
• Celgen
• CryoLife, Inc.
• DemeTECH Corporation
• Johnson & Johnson（Ethicon）
• Lincare Holdings
• Medtronic
• Omrix Biopharmaceuticals
• Pharmascience Inc.
• Porcine Biotech
• Stryker Corporation
• Terumo Corporation
• Vericel Corporation
• Zoetis

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Anti-Bleeding Gels Market to Reach US$7.8 Billion by 2030

The global market for Anti-Bleeding Gels estimated at US$5.9 Billion in the year 2024, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Veterinary Use Anti-Bleeding Gel, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$5.0 Billion by the end of the analysis period. Growth in the Human Use Anti-Bleeding Gel segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 8.9% CAGR

The Anti-Bleeding Gels market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Anti-Bleeding Gels Market - Key Trends & Drivers Summarized

Why Are Anti-Bleeding Gels Gaining Momentum in Emergency and Surgical Medicine?

The increasing reliance on anti-bleeding gels in medical care represents a significant advancement in trauma and surgical response. Traditionally, controlling bleeding has involved a combination of gauze, sutures, and manual pressure, methods that can be time-consuming and often inadequate in severe or complex injuries. Anti-bleeding gels, by contrast, offer a fast-acting, highly effective alternative that can be applied directly to wounds to stem blood flow within seconds. These gels work by accelerating the body's natural clotting mechanisms, forming a stable barrier that halts bleeding and protects the site from further injury. Their use has become particularly prevalent in emergency medicine-on battlefields, in ambulances, and during natural disasters-where rapid blood loss can be fatal if not addressed immediately. Surgical teams have also adopted anti-bleeding gels to minimize intraoperative and postoperative blood loss, thereby reducing complications and the need for transfusions. The appeal lies in their versatility; they can be used in superficial cuts, deep lacerations, and internal surgical sites alike. In many cases, the gels reduce operation time and enhance patient recovery by creating a clean, sealed wound environment that supports healing. Their compact, easy-to-use packaging makes them ideal for field medics and first responders, while their sterile formulation ensures compatibility with operating room protocols. As healthcare professionals seek faster, more efficient methods to manage bleeding, these gels are transitioning from specialty items to staples in trauma kits, surgical packs, and home first-aid supplies, signifying a paradigm shift in how bleeding is managed in both controlled and uncontrolled environments.

How Are Advances in Bioengineering Enhancing the Performance of Anti-Bleeding Gels?

The efficacy and safety of anti-bleeding gels have been significantly elevated through breakthroughs in biomaterials science and biomedical engineering. Early formulations relied on basic polysaccharides and gel-based matrices, but modern versions have advanced to include bioactive agents that work synergistically with the body’s natural hemostatic process. Many of today’s anti-bleeding gels are composed of materials such as chitosan, collagen, oxidized cellulose, and synthetic polymers, each tailored for specific types of bleeding and tissue interaction. These substances not only encourage platelet aggregation but also create a physical seal that adheres firmly to wet tissues-a crucial feature during active hemorrhage. The integration of clotting factors like thrombin and fibrinogen into gel matrices has further improved their coagulation speed and effectiveness. Additionally, some gels are now being developed with antimicrobial properties, combining bleeding control with infection prevention, especially valuable in high-risk or contaminated environments. Biodegradable and bioresorbable gels are also emerging, which dissolve naturally in the body over time and eliminate the need for removal, reducing patient discomfort and the risk of secondary complications. Innovations in nanoengineering have made it possible to produce gels with enhanced surface area, improved tissue adhesion, and faster reactivity, all of which contribute to more reliable and predictable results. Moreover, research is ongoing into smart gels that can respond to the severity of bleeding by adjusting their viscosity or releasing clotting agents in controlled doses. These technological advancements are not just improving outcomes in routine clinical settings but also making life-saving interventions possible in scenarios where conventional tools fall short, further expanding the global demand for this category of products.

Why Are Clinicians and Healthcare Institutions Rapidly Integrating Anti-Bleeding Gels Into Practice?

Healthcare institutions are increasingly integrating anti-bleeding gels into standard medical protocols due to the growing emphasis on patient safety, treatment efficiency, and surgical precision. In surgical procedures across specialties-orthopedics, cardiovascular, dental, gynecology, and neurosurgery-controlling bleeding is not only critical for visibility but also essential for reducing operation time and the risk of complications. Anti-bleeding gels provide a clean, quick solution to manage minor and moderate bleeds without the delay associated with traditional cauterization or suturing techniques. Their application is especially useful in minimally invasive procedures, where access to bleeding sites is limited, and traditional methods are impractical. Beyond the operating room, these gels are being used in outpatient and home care settings, providing clinicians with portable and efficient tools for treating bleeding wounds, ulcers, and even nosebleeds. In trauma units, gels are helping manage bleeding in patients with coagulation disorders, where clotting is otherwise impaired. Furthermore, their ease of use requires minimal training, making them an invaluable addition to emergency kits for paramedics, military medics, and disaster response teams. Hospitals and clinics are also responding to mounting pressure to reduce readmission rates and post-operative complications, and anti-bleeding gels play a role by minimizing the risks associated with prolonged bleeding or infection at surgical sites. The reduction in blood product usage, such as transfusions, also aligns with institutional cost-containment strategies and patient safety goals. With a rising number of procedures being performed on elderly and medically complex patients, clinicians are prioritizing techniques and tools that offer reliability, sterility, and speed-needs that anti-bleeding gels are uniquely positioned to meet.

What Key Drivers Are Fueling the Global Market Growth of Anti-Bleeding Gels?

The growth in the anti-bleeding gels market is driven by several key factors related to healthcare trends, product innovation, and changing clinical practices. A major driver is the global increase in surgical procedures, especially elective and minimally invasive surgeries that require precise, localized hemostasis without excessive tissue trauma. Additionally, the surge in trauma cases-due to traffic accidents, natural disasters, and armed conflicts-is generating strong demand for portable, fast-acting bleeding control solutions. Another significant factor is the aging global population, which is more prone to chronic conditions, delayed healing, and coagulation disorders, creating a sustained need for advanced hemostatic interventions. Innovations in biocompatible and multifunctional gel formulations have broadened the range of medical settings in which these products can be used, from hospital ORs to outpatient clinics and even battlefield environments. The expanding adoption of anti-bleeding gels in dental surgeries, dermatological procedures, and sports medicine is also opening new revenue streams for manufacturers. Moreover, increasing awareness of the dangers associated with blood transfusions-including infections, immune reactions, and supply shortages-is pushing healthcare providers toward alternatives that reduce blood loss and dependence on donor blood. Favorable regulatory approvals, especially in North America and Europe, are speeding up the commercialization of new formulations. In emerging economies, where access to advanced surgical tools is limited, anti-bleeding gels offer a cost-effective and highly impactful solution, thus widening the market’s geographic footprint. Strategic partnerships between biotech firms and medical distributors, along with growing investments in R&D, are further accelerating innovation and global penetration. Collectively, these factors are laying the foundation for sustained growth, making anti-bleeding gels an increasingly indispensable component of modern wound care and surgical practice.

SCOPE OF STUDY:

The report analyzes the Anti-Bleeding Gels market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Veterinary Use Anti-Bleeding Gel, Human Use Anti-Bleeding Gel); Indication (Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries, Other Indications); Distribution Channel (Retail Pharmacy Distribution Channel, Online Distribution Channel, Veterinary Pharmacy Distribution Channel, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• 3M
• Aesculap (B. Braun Melsungen)
• AngioDynamics
• Aspen Surgical
• Baxter International Inc.
• Biom'up
• Bioventus
• Celgen
• CryoLife, Inc.
• DemeTECH Corporation
• Johnson & Johnson (Ethicon)
• Lincare Holdings
• Medtronic
• Omrix Biopharmaceuticals
• Pharmascience Inc.
• Porcine Biotech
• Stryker Corporation
• Terumo Corporation
• Vericel Corporation
• Zoetis

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Anti-Bleeding Gels - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Trauma and Surgical Procedures Throws the Spotlight on Anti-Bleeding Gels
  • Adoption in Emergency Medicine and Field Applications Spurs Demand for Rapid Hemostasis Solutions
  • Advances in Biopolymer-Based Gel Formulations Enhance Bio-Absorption and Wound Compatibility
  • Expansion of Dental, ENT, and Neurosurgery Use Cases Broadens Clinical Adoption
  • Integration of Antibacterial Agents With Hemostatic Function Strengthens Dual-Purpose Efficacy
  • OEM Innovation in Preloaded Applicators Improves Ease of Use in Surgical Settings
  • Increased Preference for Animal-Free and Plant-Based Gels Supports Broader Patient Acceptance
  • Growth in Outpatient Surgeries and Daycare Procedures Drives Demand for Quick Recovery Aids
  • OEM Focus on Reabsorbable, Non-Toxic Materials Enhances Post-Operative Safety Profiles
  • Use in Military, Sports Medicine, and Disaster Relief Enhances Field Utility
  • Rising Use in Robotic and Minimally Invasive Surgery Encourages Gel-Based Hemostasis
  • Advancements in Shelf-Stable, Single-Dose Formats Support Portability and Storage Efficiency
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Anti-Bleeding Gels Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Anti-Bleeding Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Anti-Bleeding Gels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Veterinary Use Anti-Bleeding Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Veterinary Use Anti-Bleeding Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Veterinary Use Anti-Bleeding Gel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Human Use Anti-Bleeding Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Human Use Anti-Bleeding Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Human Use Anti-Bleeding Gel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Veterinary Pharmacy Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Veterinary Pharmacy Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Veterinary Pharmacy Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacy Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Retail Pharmacy Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Retail Pharmacy Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Biopsies of Soft Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Biopsies of Soft Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Biopsies of Soft Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Enucleations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Enucleations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Enucleations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Orthopedic Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Orthopedic Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Orthopedic Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• JAPAN
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• CHINA
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• EUROPE
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Anti-Bleeding Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Anti-Bleeding Gels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• FRANCE
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• GERMANY
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Anti-Bleeding Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Anti-Bleeding Gels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• INDIA
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Anti-Bleeding Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Anti-Bleeding Gels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Anti-Bleeding Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Anti-Bleeding Gels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030
• AFRICA
  • Anti-Bleeding Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Anti-Bleeding Gels by Product - Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Anti-Bleeding Gels by Product - Percentage Breakdown of Value Sales for Veterinary Use Anti-Bleeding Gel and Human Use Anti-Bleeding Gel for the Years 2014, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Anti-Bleeding Gels by Distribution Channel - Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Anti-Bleeding Gels by Distribution Channel - Percentage Breakdown of Value Sales for Veterinary Pharmacy Distribution Channel, Other Distribution Channels, Retail Pharmacy Distribution Channel and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Anti-Bleeding Gels by Indication - Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Anti-Bleeding Gels by Indication - Percentage Breakdown of Value Sales for Biopsies of Soft Tissue, Trauma, Enucleations, Orthopedic Surgeries and Other Indications for the Years 2014, 2025 & 2030

IV. COMPETITION